Does SOLIRIS Cause Thrombotic microangiopathy? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Thrombotic microangiopathy have been filed in association with SOLIRIS. This represents 1.9% of all adverse event reports for SOLIRIS.
46
Reports of Thrombotic microangiopathy with SOLIRIS
1.9%
of all SOLIRIS reports
8
Deaths
17
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From SOLIRIS?
Of the 46 reports, 8 (17.4%) resulted in death, 17 (37.0%) required hospitalization, and 2 (4.3%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOLIRIS. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does SOLIRIS Cause?
Fatigue (341)
Haemoglobin decreased (254)
Transfusion (183)
Abdominal pain (141)
Unevaluable event (140)
Dyspnoea (129)
Headache (126)
Aplastic anaemia (120)
Death (118)
Platelet count decreased (106)
What Other Drugs Cause Thrombotic microangiopathy?
TACROLIMUS (1,982)
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
Which SOLIRIS Alternatives Have Lower Thrombotic microangiopathy Risk?
SOLIRIS vs SOLOSTAR
SOLIRIS vs SOLRIAMFETOL
SOLIRIS vs SOLU-MEDROL
SOLIRIS vs SOMATREM
SOLIRIS vs SOMATROGON-GHLA